SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-031059
Filing Date
2021-12-10
Accepted
2021-12-10 06:15:10
Documents
1
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4590
  Complete submission text file 0001493152-21-031059.txt   6024
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 VALLE GRANDE ESCONDIDO CA 92025
Business Address
BROIDRICK AMY S. (Reporting) CIK: 0001822917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37428 | Film No.: 211483607